Education
About Us
Working with TipRanks
Follow Us
Entero Therapeutics (ENTO)
NASDAQ:ENTO
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -29.27K | $ -106.21K | $ -537.40K | $ -571.14K |
| Operating Income | - | $ -15.77M | $ -12.68M | $ -59.06M | $ -26.43M |
| EBITDA | - | $ -15.74M | $ -14.51M | $ -57.99M | $ -26.26M |
| Net Income | $ -18.06M | $ -15.79M | $ -14.63M | $ -58.54M | $ -32.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 163.48K | $ 3.71M | $ 1.36M | $ 8.25M | $ 6.06M |
| Total Assets | $ 85.41M | $ 6.88M | $ 5.44M | $ 11.79M | $ 12.92M |
| Total Debt | $ 140.53K | $ 826.84K | $ 883.71K | $ 1.03M | $ 628.95K |
| Net Debt | $ -22.94K | $ -2.88M | $ -479.20K | $ -7.22M | $ -5.43M |
| Total Liabilities | $ 27.61M | $ 3.28M | $ 2.70M | $ 19.61M | $ 15.56M |
| Stockholders' Equity | $ 57.80M | $ 3.60M | $ 2.74M | $ -7.82M | $ -2.64M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.22M | $ -12.88M | $ -22.34M | $ -42.61M | $ -11.23M |
| Operating Cash Flow | $ -9.22M | $ -12.38M | $ -22.34M | $ -32.29M | $ -11.22M |
| Investing Cash Flow | $ 88.17K | $ -500.00K | $ 0.00 | $ -10.32M | $ 87.35K |
| Financing Cash Flow | $ 5.58M | $ 15.23M | $ 15.74M | $ 44.76M | $ 17.05M |